
基于细胞毒性T淋巴细胞抗原4研发的生物制剂的临床应用进展
Clinical application progress of cytotoxic T lymphocyte antigen 4-based biological agents
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |